{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:15:55Z","timestamp":1790572555495,"version":"4.1.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec id=\"ab-soi260003-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Pancreatic cancer is among the deadliest malignancies, with 5-year survival estimated at 13%. Medicaid expansion offers the opportunity to assess whether broader insurance eligibility improves outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi260003-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether state-level Medicaid expansion was associated with reduced mortality and increased surgical resection among adults with pancreatic cancer and whether effects varied across demographic and socioeconomic subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi260003-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was an observational cohort study using generalized difference-in-differences Cox and logistic regression models. Data were drawn from the Surveillance, Epidemiology, and End Results (SEER) Research Plus database (2006-2019). Included were patients from a population-based registry including 12 US states with variable Medicaid expansion timelines. Patients were aged 20 to 64 years with pancreatic cancer, excluding those 65 years or older. Patients were categorized by state Medicaid expansion status as follows: nonexpansion, early (expansion in 2011), on time (expansion in 2014), and late (expansion in 2017). Groups were propensity score matched for demographic and clinical covariates. Data were analyzed between May and July 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi260003-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Residence in a state with Medicaid expansion, classified by timing. Residents of nonexpansion states served as controls in all analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi260003-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was 2-year all-cause mortality. The secondary outcome was rate of surgical resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi260003-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 51\u202f707 patients were included in this analysis; patients were categorized by state Medicaid expansion status as follows: 8758 nonexpansion, 32\u202f818 early, 6605 on time, and 3522 late. Among 51\u202f703 patients (age range, 20-64 years; 29\u202f212 male [56.5%]) diagnosed with malignant-coded pancreatic cancer, Medicaid expansion was associated with reduced 2-year mortality in early (hazard ratio [HR], 0.91; 95% CI, 0.86-0.96), on-time (HR, 0.91; 95% CI, 0.84-0.98), and late (HR, 0.94; 95% CI, 0.89-0.99) expansion states. Decreased associated mortality generally emerged after 3 years\u2019 postimplementation. Expansion narrowed geographic disparity in survival for patients in midsized (HR, 0.94; 95% CI, 0.88-1.00;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.04) and small (HR, 0.88; 95% CI, 0.79-0.98;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02) metropolitan counties but did not improve income-related disparity. Patients with stage II to III disease had an associated decrease in mortality compared with stage IV (stage II: HR, 0.91; 95% CI, 0.86-0.97;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.002; stage III: HR, 0.81; 95% CI, 0.76-0.87;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Expansion was also associated with a 19% relative increase in the odds of surgical resection (odds ratio, 1.19; 95% CI, 1.10-1.30).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi260003-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Results of this cohort study reveal that Medicaid expansion was associated with improved survival and surgical access for patients with pancreatic cancer, although improvements were delayed and uneven. Persistent income-related disparities highlight the need for additional policies to achieve equitable outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2026.0057","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:30:40Z","timestamp":1772641840000},"page":"460","source":"Crossref","is-referenced-by-count":2,"title":["Medicaid Expansion Timing and Pancreatic Cancer Resection Rates and Survival"],"prefix":"10.1001","volume":"161","author":[{"given":"Julien T.","family":"Hohenleitner","sequence":"first","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohin","family":"Gawdi","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Division of Thoracic Surgery, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"Standring","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"King","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"},{"name":"Department of Oncology, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Vitiello","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Gholami","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle K.","family":"DePeralta","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"},{"name":"Department of Surgery, Northwell Health, Manhasset, New York"},{"name":"Northwell Cancer Institute, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"soi260003r1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"soi260003r2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the US.","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"4","key":"soi260003r3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamasurg.2015.4239","article-title":"Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer.","volume":"151","author":"Shapiro","year":"2016","journal-title":"JAMA Surg"},{"issue":"8","key":"soi260003r4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jamaoncol.2020.1040","article-title":"Association of Medicaid expansion under the patient protection and affordable care act with non\u2013small-cell lung cancer survival.","volume":"6","author":"Liu","year":"2020","journal-title":"JAMA Oncol"},{"issue":"35","key":"soi260003r5","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1200\/JCO.2017.73.7817","article-title":"Changes in insurance coverage and stage at diagnosis among nonelderly patients with cancer after the Affordable Care Act.","volume":"35","author":"Jemal","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"soi260003r6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/jamaoncol.2017.3176","article-title":"Changes in insurance coverage among cancer patients under the Affordable Care Act.","volume":"4","author":"Soni","year":"2018","journal-title":"JAMA Oncol"},{"issue":"12","key":"soi260003r7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1001\/jamaoncol.2018.3467","article-title":"Comparison of insurance status and diagnosis stage among patients with newly diagnosed cancer before vs after implementation of the patient protection and Affordable Care Act.","volume":"4","author":"Han","year":"2018","journal-title":"JAMA Oncol"},{"issue":"3","key":"soi260003r8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamaoto.2019.4310","article-title":"Association of Medicaid expansion under the Affordable Care Act with stage at diagnosis and time to treatment initiation for patients with head and neck squamous cell carcinoma.","volume":"146","author":"Sineshaw","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"soi260003r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference.","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"issue":"2","key":"soi260003r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.21653","article-title":"Association of Medicaid expansion under the Affordable Care Act with insurance status, cancer stage, and timely treatment among patients with breast, colon, and lung cancer.","volume":"3","author":"Takvorian","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"soi260003r11","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1245\/s10434-023-13562-9","article-title":"The impact of Medicaid expansion on early-stage hepatocellular carcinoma care.","volume":"30","author":"Lima","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"soi260003r12","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/jnci\/djab135","article-title":"Early Medicaid expansion and cancer mortality.","volume":"113","author":"Barnes","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"soi260003r13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.amjsurg.2022.09.004","article-title":"Medicaid expansion and surgery for HPB\/GI cancers: NCDB difference-in-differences analysis.","volume":"225","author":"Kaelberer","year":"2023","journal-title":"Am J Surg"},{"issue":"3","key":"soi260003r14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/jso.26515","article-title":"Medicaid expansion and the management of pancreatic cancer.","volume":"124","author":"Hoehn","year":"2021","journal-title":"J Surg Oncol"},{"issue":"5","key":"soi260003r15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1377\/hlthaff.26.5.1459","article-title":"Access to specialty care and medical services in community health centers.","volume":"26","author":"Cook","year":"2007","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"soi260003r16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1056\/NEJMsa040609","article-title":"Primary care physicians who treat Blacks and Whites.","volume":"351","author":"Bach","year":"2004","journal-title":"N Engl J Med"},{"key":"soi260003r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8441","article-title":"Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the US, Sweden, UK, and Denmark.","volume":"346","author":"Lee","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"soi260003r18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MLR.0000000000000467","article-title":"Racial and ethnic disparities in health care access and utilization under the Affordable Care Act.","volume":"54","author":"Chen","year":"2016","journal-title":"Med Care"},{"issue":"3","key":"soi260003r19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/cncr.32563","article-title":"The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the US.","volume":"126","author":"Corrigan","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"soi260003r20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/SLA.0000000000006177","article-title":"Association of Medicaid expansion with reduction in racial disparities in the timely delivery of upfront surgical care for patients with early-stage breast cancer.","volume":"280","author":"Tamirisa","year":"2024","journal-title":"Ann Surg"},{"issue":"49","key":"soi260003r22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018082","article-title":"Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013.","volume":"98","author":"Tramontano","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"soi260003r21","unstructured":"Haught? R, Coleman? A, Dobson? A, Richards? C, McGuire? C. Federal cuts to Medicaid could end Medicaid expansion and affect hospitals in nearly every state\u2014the Commonwealth Fund. Accessed November 1, 2025. https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2025\/may\/federal-cuts-medicaid-could-end-medicaid-expansion-affect-hospitals"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2845816\/jamasurgery_hohenleitner_2026_oi_260003_1778616123.90623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:01:21Z","timestamp":1778684481000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2845816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2026.0057","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}